Purchase Order W81K0022P0154

Award Date 7/1/22
Potential Completion Date 9/30/27
Potential Value $1.9M
Federal Agency
Medical Command
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
North Chicago, IL 60064, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command awarded a firm fixed price purchase order contract to Abbott Laboratories Inc. for automated chemistry and immunoassay testing services. The $1,912,860.98 contract has a performance period through October 31, 2024 and was awarded on October 1, 2019. The services will be provided at Abbott's North Chicago, Illinois facility. This award is not associated with a set-aside program. Abbott Laboratories is a large pharmaceutical and medical device...
This is a definitive, firm fixed price contract awarded to Abbott Laboratories Inc., through its Abbott Diagnostics Division, by the U.S. Army Medical Command (MEDCOM) in the amount of $4,406,749.11. The contract is for chemistry and immunology testing services, including the provision of two chemistry analyzers, two immunology analyzers, associated equipment, middleware, reagents, supplies, maintenance, and training to support operations at Eisenhower Army Medical Center in Augusta, Georgia....
This federal contract award is for the delivery of REAGENTS from Abbott Laboratories Inc. to the U.S. Department of the Army Medical Command (MEDCOM). The $156,353.35 firm fixed-price delivery order is issued under the Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) contract, a General Services Administration (GSA) indefinite delivery vehicle. No set-aside designation was used. Abbott Laboratories Inc., a global healthcare company, is the prime contractor. The award...
This federal contract award to Abbott Laboratories Inc. is for the provision of CLINICAL CHEMISTRY/IMMUNOASSAY REAGENTS, awarded by the U.S. Army Medical Command (MEDCOM) under the General Services Administration (GSA) Federal Supply Schedule for Critical Analyzers, Laboratory (FSS-66-III). The contract has a ceiling value of $5,595,127.58 and is a Firm Fixed Price Delivery Order with a period of performance through March 31, 2019. The award was made on March 1, 2016 without a set-aside...
Abbott Laboratories Inc., Abbott Diagnostics Division, was awarded a $1,279,296.02 firm fixed price purchase order by the Department of the Army Medical Command to provide clinical chemistry and immunoassay testing and analysis services. The contract has a period of performance from April 1, 2020 to September 30, 2020 and will deliver these services in support of William Beaumont Army Medical Center in El Paso, Texas. The original solicitation sought interim chemistry and immunoassay testing...
This is a $712,573.88 firm fixed price purchase order awarded by the Department of the Army Medical Command to Abbott Laboratories Inc. for the provision of clinical chemistry and immunoassay assays. The contract has no set-aside designation. Abbott Laboratories, through its Abbott Diagnostics Division, has provided a wide variety of laboratory equipment, reagents, and testing services to federal agencies including the Department of Veterans Affairs, Defense Health Agency, and Department of...
The Department of the Army Medical Command awarded a firm fixed price purchase order contract to Abbott Laboratories Inc. to provide an architect analyzer for chemistry and immunoassay testing. The contract period of performance is from October 1, 2022 to September 30, 2023 and the potential value is $178,501.00. The contract is not set aside for any specific business type. As a major medical device and pharmaceutical manufacturer, Abbott Laboratories provides a wide range of healthcare products...
This is a federal contract award to Abbott Laboratories Inc. by the Department of the Army Medical Command for the provision of clinical chemistry and immunoassay supplies. The contract is a Delivery Order issued under Abbott's existing General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers, Laboratory. The contract has a potential value of $2,511,922.58 and a completion date of October 31, 2021. No set-aside designation is specified. As a major...
The Department of the Army Medical Command awarded a firm fixed price purchase order contract to Abbott Laboratories Inc., through its Abbott Diagnostics Division, for $657,599.98 to provide clinical chemistry and immunoassay testing services and associated equipment and consumables to support laboratory operations at the William Beaumont Army Medical Center in El Paso, Texas. This appears to be a bridge contract to allow for the continuance of critical laboratory testing while a follow-on...
This federal contract award is for CHEMISTRY TESTING services provided by Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, to the Department of the Army Medical Command. The $345,447.24 Firm Fixed Price contract was awarded on October 1, 2020 with a completion date of September 30, 2021. It was not set aside for any specific business type. Through its Abbott Diagnostics Division, Abbott has extensive experience providing a variety of clinical laboratory...

The U.S. Army Medical Command (MEDCOM) awarded a $1,902,165.00 firm-fixed-price purchase order to Abbott Laboratories Inc. for anti-HCV immunoassay testing services. The contract has a completion date of September 30, 2027 and does not have a set-aside designation. The contract was awarded under the Department of Veterans Affairs' General Services Administration Federal Supply Schedule for Critical Analyzers and Laboratory equipment, which Abbott Laboratories Inc. holds. The immunoassay testing services are in support of clinical laboratory operations at the San Antonio Military Medical Center to aid in the diagnosis of hepatitis, autoimmune thyroid disease, and managing patients receiving tacrolimus therapy.

Generated 3/11/25, 9:48 AM